Viral Hepatitis Program


The Viral Hepatitis Program is a federally funded State of Maine program dedicated to preventing and controlling viral hepatitis.  This involves collaborating with local, state, and national public health programs that work with high risk individuals e.g. STD, HIV, Immunization, and Infectious Disease, as well as correctional health, substance abuse treatment programs, syringe exchange, and health care organizations providing primary and specialty care and treatment.

Primary Activities

  • Training, providing technical assistance and hepatitis C antibody test kits for testing and counseling sites serving adults at high risk for hepatitis C statewide;
  • Training, providing technical assistance and adult hepatitis A and B vaccine statewide for adults at risk for viral hepatitis;
  • Maintaining a viral hepatitis resource guide to assist with coordination of linkage to care for medical evaluation;  
  • Training and educating the general public and professionals serving persons at-risk about viral hepatitis through events such as Hepatitis Awareness Month;
  • Providing consultation for professionals and the public about viral hepatitis prevention, transmission, diagnosis, and treatment;
  • Promoting awareness about the scope of hepatitis C epidemic among the general public, persons at-risk and health and social service professionals;
  • Chair Viral Hepatitis Task Force (TBD)
  • Development of educational materials for hepatitis B/C prevention among high risk groups.
  • Collaboration with the Maine Harm Reduction Alliance on drug user health issues

Sample Indicators

  • Number, rates, proportion of hepatitis C infection for acute and chronic infections.  These data are available by basic demographic and in some cases risk factor information. Data is primarily shared via the following reports:
    • Annual Epidemiologic Reports
    • Individual data requests

Data Collected and Available:

  • Aggregate demographics, hepatitis C risk factors (for some data), and hepatitis C test results.
  • Number of adult hepatitis vaccine doses administered by site through State Program

Preliminary 2013 Data

  • Number of chronic hepatitis C cases: 1,263
  • Number of acute hepatitis C cases: 8
  • Estimated persons infected with hepatitis C in Maine: 21-26,000*
  • Number of unduplicated persons reported to Maine CDC since 1997: ~18,000

Cross Program Collaborations:  Chair Division Cross-Program Viral Hepatitis Work Group, ongoing collaboration with HIV and STD contracted sites to provide free hepatitis C testing and counseling; ongoing collaboration with Immunization to provide free adult hepatitis vaccine to 13 sites. Collaborated with Infectious Disease Epidemiology to transition acute and chronic hepatitis epidemiology and surveillance to Infectious Disease Epidemiology in June 2013.


The Viral Hepatitis Program currently receives funding from the following sources:

  • U. S. CDC, Division of Viral Hepatitis (2013-2014): $109,022

Staff Capacity

1 Full Time Employee
1 4 hour/week Employee

Resource Tools:

National Affiliations

U.S. CDC, Division of Viral Hepatitis 
National Alliance of State and Territorial AIDS Directors (NASTAD)

*Estimate based on U.S. CDC prevalence estimate of 1.6%.  Does not include institutionalized populations.